Viewing Study NCT07175220


Ignite Creation Date: 2025-12-25 @ 4:19 AM
Ignite Modification Date: 2025-12-26 @ 3:21 AM
Study NCT ID: NCT07175220
Status: RECRUITING
Last Update Posted: 2025-11-18
First Post: 2025-09-09
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase II Clinical Study of SHR2554 Tablets Combined With Other Anti-tumor Treatments in Non-small Cell Lung Cancer Subjects
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module